Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

ELI LILLY AND COMPANY

(LLY)
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
Beroep
Logo Eli Lilly and Company
Eli Lilly and Company is een van de grootste farmaceutische concerns ter wereld. De netto-omzet is als volgt verdeeld naar therapeutisch gebied:

- endocrinologie (48,2%): producten voor de behandeling van osteoporose, diabetes en groeiproblemen;

- oncologie (21,7%);

- immunologische ziekten (10%);

- neurologie (7,5%): vooral middelen voor de behandeling van depressie en schizofrenie;

- overige (12,6%).

De netto-omzet is geografisch als volgt verdeeld: Verenigde Staten (58%), Europa (17,1%), Japan (10,5%), China (4,6%) en overig (9,8%).

Aantal werknemers : 35 000 mensen.
Verkoop per activiteit
20192020Delta
Pharmaceutical Products22 319.50100%24 539.80100% +9.95%
USD in miljoenen
Verkoop per regio
2020
United States14 229.3058%
Europe4 187.7017.1%
Japan2 583.1010.5%
Other Foreign Countries2 422.709.9%
China1 116.904.6%
USD in miljoenen
Managers
Naam Titel Leeftijd Van
David Ricks Chairman, President & Chief Executive Officer 52 2017
Anat Ashkenazi Chief Financial Officer & Senior Vice President 47 2021
Timothy Garnett Chief Medical Officer & VP-Global Medical - 1998
Daniel Skovronsky Chief Scientific Officer & Senior Vice President 46 -
Diogo Rau Senior VP, Chief Information & Digital Officer - 2021
Alonzo Weems Senior VP, Chief ethics & Compliance Officer - 2021
Jon Erik Fyrwald Independent Director 62 2005
Michael L. Eskew Independent Director 70 2008
Ralph Alvarez Independent Director 65 2009
Katherine Baicker, Dr. Independent Director 48 2011
Bestuurders
Naam Titel Leeftijd Van
David Ricks Chairman, President & Chief Executive Officer 52 2017
Jon Erik Fyrwald Independent Director 62 2005
Michael L. Eskew Independent Director 70 2008
Ralph Alvarez Independent Director 65 2009
Katherine Baicker, Dr. Independent Director 48 2011
William G. Kaelin, Dr. Independent Director 62 2012
Marschall S. Runge, Dr. Independent Director 65 2013
Jackson Peter Tai Independent Director 69 2013
Juan Luciano Lead Independent Director 58 2019
Jamere Jackson Independent Director 51 2016
Aandelen
Stemming AantalPercentage vrij verhandelbaarBedrijfseigen aandelenDrijvend Totaal
Aandeel A 1 957 055 393 955 141 904 99.8% 463 000 0.0% 99.8%
Aandeelhouders
NaamAandelen%
Capital Research & Management Co. 109 033 091 11,4%
Lilly Endowment, Inc. 107 853 610 11,3%
The Vanguard Group, Inc. 65 601 890 6,86%
PNC Bank, NA (Investment Management) 52 105 187 5,45%
The PNC Financial Services Group, Inc. 52 012 151 5,44%
SSgA Funds Management, Inc. 33 115 881 3,46%
PRIMECAP Management Co. 32 700 986 3,42%
T. Rowe Price Associates, Inc. (Investment Management) 30 256 081 3,16%
Wellington Management Co. LLP 28 382 066 2,97%
Fidelity Management & Research Co. LLC 26 298 542 2,75%
Participaties
NaamAandelen%Totale waarde
DICERNA PHARMACEUTICALS, INC. (DRNA) 5 414 185 6,97% 112 669 190 USD
IMMUNOCORE HOLDINGS PLC 2 548 145 6,25% 98 154 545 USD
AVIDITY BIOSCIENCES, INC. (RNA) 2 319 396 4,95% 52 186 410 USD
PRECISION BIOSCIENCES, INC. (DTIL) 3 762 190 6,31% 35 703 183 USD
PROQR THERAPEUTICS N.V. (PRQR) 3 989 976 6,23% 30 802 615 USD
NEXTCURE, INC. (NXTC) 2 088 859 7,57% 17 170 421 USD
SIGILON THERAPEUTICS, INC. (SGTX) 2 744 443 8,56% 14 792 548 USD
LEAP THERAPEUTICS, INC. (LPTX) 1 819 758 2,09% 5 077 125 USD
AC IMMUNE SA (ACIU) 0 0,0000%
Markten en indexen
- International Market
- S&P 100 / S&P 500, Stoxx Americas 100, Stoxx Global 200
Beurscodes
- Bloomberg-code :  LILY11B:BZ
- Reuters Code :  
- Datastreamcode :  
Bedrijfsgegevens
Eli Lilly and Company
Lilly Corporate Center
IN 46285 Indianapolis, Indiana

Telefoon : +1 617-225-3226
Fax :
Internet : https://investor.lilly.com/
Merkenportefeuille
In samenwerking metMijn merken op de beurs
Meer merken vanEli Lilly and Company
Sector Farmaceutische producten - Andere
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
ELI LILLY AND COMPANY50.93%231 027
JOHNSON & JOHNSON1.16%419 109
ROCHE HOLDING AG16.05%336 162
PFIZER, INC.46.70%303 095
NOVO NORDISK A/S67.00%247 254
ABBVIE INC.8.74%205 976
MERCK & CO., INC.-3.23%199 954
NOVARTIS AG-10.68%181 102
ASTRAZENECA PLC14.84%173 523
BRISTOL-MYERS SQUIBB COMPANY-8.87%125 477
SANOFI8.02%120 755
AMGEN INC.-12.54%113 267
GLAXOSMITHKLINE PLC12.58%100 759
CHUGAI PHARMACEUTICAL CO., LTD.-30.95%56 933
JIANGSU HENGRUI MEDICINE CO., LTD.-45.00%52 191
BAYER AG-5.43%50 628
DAIICHI SANKYO COMPANY, LIMITED-17.62%49 746
TAKEDA PHARMACEUTICAL COMPANY LIMITED-18.11%43 512
ASTELLAS PHARMA INC.15.21%30 934
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY42.86%23 703
CATALENT, INC.27.14%22 650